Can a Large Number of Transplanted Mesenchymal Stem Cells Have an Optimal Therapeutic Effect on Improving Ovarian Function?
Open Access
- 16 December 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (24) , 16009
Abstract
Mesenchymal stem cells (MSCs) are next-generation treatment in degenerative diseases. For the application of mesenchymal stem cell therapy to degenerative disease, transplantation conditions (e.g., optimized dose, delivery route and regenerating efficacy) should be considered. Recently, researchers have studied the mode of action of MSC in the treatment of ovarian degenerative disease. However, the evidence for the optimal number of cells for the developing stem cell therapeutics is insufficient. The objective of this study was to evaluate the efficacy in ovarian dysfunction, depends on cell dose. By intraovarian transplantation of low (1 × 105) and high (5 × 105) doses of placenta-derived mesenchymal stem cells (PD-MSCs) into thioacetamide (TAA)-injured rats, we compared the levels of apoptosis and oxidative stress that depend on different cell doses. Apoptosis and oxidative stress were significantly decreased in the transplanted (Tx) group compared to the non-transplanted (NTx) group in ovarian tissues from TAA-injured rats (* p < 0.05). In addition, we confirmed that follicular development was significantly increased in the Tx groups compared to the NTx group (* p < 0.05). However, there were no significant differences in the apoptosis, antioxidant or follicular development of injured ovarian tissues between the low and high doses PD-MSCs group. These findings provide new insights into the understanding and evidence obtained from clinical trials for stem cell therapy in reproductive systems.Keywords
Funding Information
- National Research Foundation of Korea (2017M3A9B4061665)
- PLABiologicsCo., Ltd.
This publication has 39 references indexed in Scilit:
- Mitochondrial dysfunction and oxidative stress in aging and cancerOncotarget, 2016
- Clinical Trials with Mesenchymal Stem Cells: An UpdateCell Transplantation, 2016
- ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age‐Related DiseasesOxidative Medicine and Cellular Longevity, 2016
- Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat ModelBioMed Research International, 2016
- The Therapeutic Effects of Optimal Dose of Mesenchymal Stem Cells in a Murine Model of an Elastase Induced-EmphysemaTuberculosis and Respiratory Diseases, 2015
- Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicineExperimental & Molecular Medicine, 2013
- Choice of cell-delivery Route for Successful Cell Transplantation Therapy for the HeartFuture Cardiology, 2013
- Anti‐fibrotic effect of chorionic plate‐derived mesenchymal stem cells isolated from human placenta in a rat model of CCl4‐injured liver: Potential application to the treatment of hepatic diseasesJournal of Cellular Biochemistry, 2010
- Methods for quantifying follicular numbers within the mouse ovaryReproduction, 2004
- Metformin in polycystic ovary syndrome: systematic review and meta-analysisBMJ, 2003